Eckerd/Turley Centennial Endowed Professor of Health Outcomes & Pharmacy Practice
at The University of Texas College of Pharmacy
Dr. Karen Rascati’s research interests include economic and outcomes evaluations for several disease states as well as for pharmacy services. She has conducted over 60 funded research projects and has served on various grant review panels. She has supervised 40 MS and 25 PhD graduate student projects. She has authored or co-authored more than 100 publications (including five textbook chapters) and more than 100 national and international presentations. Her textbook, Essentials of Pharmacoeconomics was published in 2008, and was translated into Portuguese in 2009. In addition, she received the 2009 University of Texas Hamilton Book Award. The second edition became available in 2013.
Gupte-Singh K, Wilson JP, Barner JC, Richards KM, Rascati KL, Hovinga, C. Patterns of antiepileptic drug use in patients with potential refractory epilepsy in Texas Medicaid. Accepted to Epilepsy & Behavior, 2018.
Grisham-Takac C, Lai P, Srinivasa M, Vasquez L, Rascati KL. Correlation of Antidepressant Target Dose Optimization and Achievement of Glycemic Control. Accepted by The Mental Health Clinician (MHC) CPNP Journal, 2018.
Makhinova T, Barner JC , Brown CM, Richards KM, Rascati KL, Barnes N, Nag A. Adherence enhancement for patients with asthma in community pharmacy practice: tools development and pharmacists’ feedback. Accepted by Journal of Pharmaceutical Health Services Research.
Rascati K. Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”. Drugs in R&D. September 2017;17(3):487-488.
Ogunsanya M, Bamgbade B, Thach A, Sudhapalli P, Rascati K. Determinants of health-related quality of life in international graduate students. Currents in Pharmacy Teaching & Learning. April 2018;10(4):413-422.
Heo J, Rascati KL, Moffett B, Lopez KN. Association of Fractures with Furosemide Use in Pediatric Patients with Congenital Heart Disease. Pediatrics, accepted with revisions.
Ogunsanya M, Bamgbade B, Rascati KL. Determinants of Health-Related Quality Of Life in International Graduate Students. Currents in Pharmacy Teaching and Learning. accepted with revisions.
Popp R, Patel U, Davis M, Rascati KL. Using a Claims-based Algorithm to Estimate Biologic Medication Effectiveness and Medication Cost per Effectively-treated Patient in Rheumatoid Arthritis. Journal of Managed Care & Specialty Pharmacy –accepted with revisions.
Nguyen T, Rasati KL, Temple H. Comparison of Medication Adherence Simulation in Professional Pharmacy Students versus Undergraduate Students. Currents in Pharmacy Teaching and Learning. In press.
Alefan Q, Rascati K. Pharmacoeconomic Studies in World Health Organization Eastern Mediterranean Countries: Reporting Completeness. International Journal of Technology Assessment in Health Care June 5, 2017;1-7.
Rascati K. Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”. Drugs in R&D, May 20, 2017
Heo J, Rascati K, Lee E. Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea. Value in Health Regional Issues. May 2017;12:7-19.
Ling Y, Rascati K, Pawaskar M. Direct and indirect costs among patients with binge-eating disorder in the United States. International Journal of Eating Disorders. May 2017;50(5):523-532.
Rascati K, Worley K, Meah Y, Everhart D. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 inhibitors. Journal of Managed Care & Specialty Pharmacy. March 2017;23(3):299-306.
Tran M, Xiang P, Stanford R, et al. Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission. Journal of Managed Care & Specialty Pharmacy. October 2016;22(10):1186-1193.
Hinds A, Lopez D, Rascati K, Jokerst J, Srinivasa M. Adherence to the 2013 Blood Cholesterol Guidelines in Patients With Diabetes at a PCMH: Comparison of Physician Only and Combination Physician/Pharmacist Visits. The Diabetes educator. 2016; 42(2):228-33.
Kim G, Barner JC, Rascati K, Richards K. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis. Clinical therapeutics. 2016; 38(3):646-54.
Park H; Rascati KL; Keith MS, Managing oral phosphate binder medication expenditures within the medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. Dialysis organizations. Journal of Managed Care & Specialty Pharmacy [J Manag Care Spec Pharm], ISSN: 2376-1032, 2015 Jun; Vol. 21 (6), pp. 507-14